Chinook Therapeutics
KDNY
$40.39
Share price
0.00%
Change (1 day)
109.71%
Change (1 year)
Categories
P/S ratio for Chinook Therapeutics (KDNY)
P/S ratio as of May 2024 (TTM): 463
According to Chinook Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 463.007. At the end of 2023 the company had a P/S ratio of 440.
P/S ratio history for Chinook Therapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 440 | 61.08% |
| 2022 | 273 | 1484.47% |
| 2021 | 17.3 | -88.13% |
| 2020 | 145 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |